AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

aap Implantate AG

Share Issue/Capital Change Sep 20, 2007

10_rns_2007-09-20_f6b7e25d-96a6-425f-997c-837c817dbf38.html

Share Issue/Capital Change

Open in Viewer

Opens in native device viewer

News Details

Ad-hoc | 20 September 2007 18:44

aap Implantate AG: Fame Medical Group Takeover Completed Successfully

aap Implantate AG / Acquisition/Capital Increase

Release of an Ad hoc announcement according to § 15 WpHG, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.


aap today completed the acquisition of all shares in the Dutch FAME Holding
B.V. Group and its subsidiaries with the commercial register entry.

The capital increase by a contribution in kind agreed at the extraordinary
general meeting of aap Implantate AG held on February 15, 2007 was today
entered into the commercial register. Lawsuits filed by individual
shareholders had delayed the entry. aap thereupon embarked on fast track
proceedings, an option available since 2006 that is intended to enhance the
legal and procedural security of companies affected by lawsuits filed in
connection with shareholders’ meetings.

The register entry increases aap Implantate AG’s capital stock by EUR
8,448,999.00 to EUR 25,347,156.00, divided into 25,347,156 individual share
certificates.

Listing of the new shares for stock market trading is planned for the weeks
ahead. Due to contractual provisions 50 percent of the new shares are
subject to a 12-month lock-up period after listing.

Contact:
Bei Rückfragen wenden Sie sich bitte an:
aap Implantate AG; Nanette Hüdepohl; Investor & Public Relations; Lorenzweg
5; D-12099 Berlin
Tel.: ++49/30/750 19 – 133; Fax.: ++49/30/750 19 – 290; [email protected]

20.09.2007 Financial News transmitted by DGAP

Language: English
Issuer: aap Implantate AG
Lorenzweg 5
12099 Berlin
Deutschland
Phone: +49 (0) 30 75 01 90
Fax: +49 (0) 30 75 01 91 11
E-mail: [email protected]
Internet: www.aap.de
ISIN: DE0005066609
WKN: 506660
Listed: Geregelter Markt in Frankfurt (Prime Standard); Freiverkehr
in Berlin, Hannover, Düsseldorf, Hamburg, München, Stuttgart

End of News DGAP News-Service


Talk to a Data Expert

Have a question? We'll get back to you promptly.